User Panel
Too many docs & hospitals involved and actual trials going on to be a pump and dump....and our congressional rep visited the company, she was also pictured with the whitehouse covid taskforce shortly afterwards. anecdotal, but interesting.
Just trying to share info is all I'm doing. I have money to risk. If you don't have money to risk, don't play. |
|
Are you guys still holding this or have you taken profits and bounced?
|
|
Sadly, I bought higher than it is right now. But it's only a couple thousand dollars, so I'm holding.
However, I did buy AMZN back in March. So, I'm up overall. |
|
I'm long and holding until uplisting or FDA comments. The latest press release is good news, https://www.cytodyn.com/newsroom/press-releases/detail/456/cytodyn-receives-positive-dsmc-recommendation-for Phase 3 trial of severe to critical patients to continue, but some were hoping for the Data safety committee to halt the phase 3 trial so the placebo group could get the drug, which would be an unusual but strong action supporting emergency approval.
|
|
@captainpooby - Bought some PYRNF today. The technology and company look interesting and the chart looks good. Not a fan of such low volume but it's not a large position.
Been watching CYDY to get back in but it keeps trending down. It might just be testing the 20MA so I'm going to continue to keep an eye on it. Might enter a position tomorrow or Friday. |
|
Quoted: @captainpooby - Bought some PYRNF today. The technology and company look interesting and the chart looks good. Not a fan of such low volume but it's not a large position. Been watching CYDY to get back in but it keeps trending down. It might just be testing the 20MA so I'm going to continue to keep an eye on it. Might enter a position tomorrow or Friday. View Quote Good luck. Next few weeks should be interesting. They may have the Navy contract signed in days. |
|
Quoted: @captainpooby - Bought some PYRNF today. The technology and company look interesting and the chart looks good. Not a fan of such low volume but it's not a large position. Been watching CYDY to get back in but it keeps trending down. It might just be testing the 20MA so I'm going to continue to keep an eye on it. Might enter a position tomorrow or Friday. View Quote which service did you use to buy? Vanguard wanted a commission plus $50 because it is a foreign OTC. |
|
|
|
my biggest winner is SPrint so far, pre softbank i purchased $750 worth (around 2012 i think). its now T mobile of course and is $4600.
|
|
|
|
Guy I know was harping this CYDY crap on insta, I got suckered and stupidly bought in the bull trap at $6.67. Holding a nice bag. Fuck
|
|
Interesting chart for investors. What teens buy and where they spend their money including top brands....
40th Semi-Annual Taking Stock With Teens Survey, Fall 2020 |
|
Checked this forum for the first time in a few months and found this thread. It's interesting to track the performance in hindsight of this one, after all the hype the OP gave it.
For those that jumped in on this one, was it one you were considering before the OP posted about it? |
|
Quoted: I bought this stock a couple years ago for pennies... I'm not affiliated or work for this company, but they are local to me. Take a look at CYDY. The company is OTC but, they are on fast track FDA approval and trials are going very well. DO your research, but this stock has steadily climbed from .60 to $4.48 and is set to go even higher IMO. They are working on an NYSE uplisting and a recent TED talk got the PR wheels in motion. I'm expecting $30+in a few months. It can't hurt to take a look! View Quote Do you by chance sell timeshares as well? |
|
No, but I did retire at 37yo. This stock is sucking balls right now. supposedly good news tomorrow after the close. There's an investor presentation at 2pm pacific.
|
|
Bought in at 4.60 and now 5.20. Guess I should sell. Womp womp.
|
|
Go read the yahoo finance conversation board for some insight... yeah I know, but the quality of info is actually pretty good. Just finished phase 3 trials last week, and are awaiting data results. VERY bullish. NOT a day trade.
|
|
Yeah, that is pretty bullish. I am not in for much so I am goi g to hold and see what happens.
|
|
https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-021-01391-1
The latest article / paper on leronlimab |
|
It's an OTC. They've filed for Nasdaq, but are in limbo until shareholder equity minimum is resolved and their phase 3 trail data is published.
|
|
I have one and only one question. Have you read the prospectus?
|
|
I've read every SEC doc filed. Have you seen the latest news?
FDA wants raw data from phase 3 trial ASAP. Compassionate use approved for Philippines and cydy has allocated 100,000 vials. (solves shareholder equity requirement for Nasdaq) Nagging lawsuit settled, clearing path for uplist. Big week ahead. YMMV - just providing a heads up. Do your own DD. |
|
https://finance.yahoo.com/quote/CYDY?p=CYDY&.tsrc=fin-srch
NEWS link, and cydy is in the trending tickers section on Yahoo. Yahoo conversation board has plenty of good info from "Relevant" posters. Reddit just opened up a subreddit on cydy and it's blowing up. |
|
r/cydy is picking up steam and posting lots of good info... reddit r/cydy
|
|
Assume I know nothing because that's the truth. How and where do I buy into this ?
|
|
You can buy it on TD Ameritrade, or call a broker. I bet you can buy it on E trade too.
I know you can't buy it on robin hood or we bull. |
|
Cool. I'm almost back to even. Bought a while back around $8. Ouch.
|
|
|
Shit, sorry guys, I expect you'll be above water this week for sure. Go read the analysis that "Thoughtful Investing" has done on share price. It should give you some confidence to hold.
|
|
I bought last summer at $4.40 and thought it was a dog for a while and almost dumped it. But after reading some of the links and looking at the Reddit forum I am going to see how it plays out for a while.
|
|
|
I've made a shit-ton on NVAX and VXRT in the last week. Liquidated and likely moving into CYDY again...good luck all.
|
|
CytoDyn's Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab
https://www.cytodyn.com/investors/news-events/press-releases/detail/501/cytodyns-phase-3-trial-demonstrates-safety-a-24 |
|
Yep, been averaging down again. added 20k shares. Conf Call tomorrow, with updates on EUA filings. IF you read all the BS lawyer press on yahoo, you'll see that it's mostly all BS. They've copy pasted similar press from GNUS, and even used their CEOs name and their stock price accidentally.
SOON. |
|
CYDY is my biggest loser in my portfolio. 50% loss. Do y'all really think it will bounce back up?
And I see there is a class action lawsuit and negative press around it too: CYTODYN, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP notifies investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York 8:00 am ET March 23, 2021 (Globe Newswire) Print Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed against CytoDyn, Inc. ("CytoDyn" or the "Company") (OTCQB: CYDY) in the United States District Court for the Western District of Washington on behalf of those who purchased or acquired the securities of CytoDyn between March 27, 2020 and March 9, 2021, inclusive (the "Class Period"). All investors who purchased shares of CytoDyn, Inc. and incurred losses are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action or join the case on our website www.whafh.com. If you have incurred losses in the shares of CytoDyn, Inc., you may, no later than May 17, 2021, request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in the shares of CytoDyn, Inc. CLICK HERE TO JOIN CASE |
|
No one can say whether it will bounce or not but I know I won't touch it again most likely. I will need some very compelling evidence for me to change my opinion of it.
|
|
Securities fraud class action lawsuit filed 3/19/21 on cytodyn might as well hold - shares down 65 per cent and see if you get a settlement years from now since we’ve already lost! What a turd.
|
|
I'm down $200k, but Im not selling. EUA applied for...and Other indications are still strong. BIOTECH not for weak stomachs.
|
|
|
|
They filed around March 10th I think... it was clarified on the last conference call, and mentioned in the press release on March 18th.
I'm in a private chat with several larger investors and several doctors that have used Leronlimab. Approval is coming. Today's price action was in direct response to the current press release. It also appears that the company has finally hired a professional to write the releases. (thank God). |
|
Sign up for the ARFCOM weekly newsletter and be entered to win a free ARFCOM membership. One new winner* is announced every week!
You will receive an email every Friday morning featuring the latest chatter from the hottest topics, breaking news surrounding legislation, as well as exclusive deals only available to ARFCOM email subscribers.
AR15.COM is the world's largest firearm community and is a gathering place for firearm enthusiasts of all types.
From hunters and military members, to competition shooters and general firearm enthusiasts, we welcome anyone who values and respects the way of the firearm.
Subscribe to our monthly Newsletter to receive firearm news, product discounts from your favorite Industry Partners, and more.
Copyright © 1996-2024 AR15.COM LLC. All Rights Reserved.
Any use of this content without express written consent is prohibited.
AR15.Com reserves the right to overwrite or replace any affiliate, commercial, or monetizable links, posted by users, with our own.